168 related articles for article (PubMed ID: 17311616)
1. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease.
Mendez-Sanchez N; Zamora-Valdes D; Pichardo-Bahena R; Barredo-Prieto B; Ponciano-Rodriguez G; Bermejo-Martínez L; Chavez-Tapia NC; Baptista-González HA; Uribe M
Liver Int; 2007 Mar; 27(2):215-9. PubMed ID: 17311616
[TBL] [Abstract][Full Text] [Related]
2. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
3. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis.
Bragoszewski P; Habior A; Walewska-Zielecka B; Ostrowski J
Acta Biochim Pol; 2007; 54(2):341-8. PubMed ID: 17502923
[TBL] [Abstract][Full Text] [Related]
4. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.
Wieckowska A; Zein NN; Yerian LM; Lopez AR; McCullough AJ; Feldstein AE
Hepatology; 2006 Jul; 44(1):27-33. PubMed ID: 16799979
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
Akyildiz M; Gunsar F; Nart D; Sahin O; Yilmaz F; Akay S; Ersoz G; Karasu Z; Ilter T; Batur Y; Berdeli A; Akarca U
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):192-8. PubMed ID: 19829123
[TBL] [Abstract][Full Text] [Related]
7. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of Ob-Rb and its relationship with the overexpression of TGF-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis.
Cayón A; Crespo J; Mayorga M; Guerra A; Pons-Romero F
Liver Int; 2006 Nov; 26(9):1065-71. PubMed ID: 17032406
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
[TBL] [Abstract][Full Text] [Related]
10. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.
Gong JP; Onaivi ES; Ishiguro H; Liu QR; Tagliaferro PA; Brusco A; Uhl GR
Brain Res; 2006 Feb; 1071(1):10-23. PubMed ID: 16472786
[TBL] [Abstract][Full Text] [Related]
12. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
[TBL] [Abstract][Full Text] [Related]
13. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain.
Onaivi ES
Neuropsychobiology; 2006; 54(4):231-46. PubMed ID: 17356307
[TBL] [Abstract][Full Text] [Related]
15. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
Helling TS; Helzberg JH; Nachnani JS; Gurram K
Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Terra X; Martinez S; Aguilar C; Filiu E; Alibalic A; Sabench F; Hernández M; Del Castillo D; Richart C
Biomed Res Int; 2014; 2014():502542. PubMed ID: 24864249
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
[TBL] [Abstract][Full Text] [Related]
18. Pathology of nonalcoholic fatty liver disease.
Yeh MM; Brunt EM
Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208
[TBL] [Abstract][Full Text] [Related]
19. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis.
Ibañez P; Solis N; Pizarro M; Aguayo G; Duarte I; Miquel JF; Accatino L; Arrese M
J Gastroenterol Hepatol; 2007 Jun; 22(6):846-51. PubMed ID: 17565640
[TBL] [Abstract][Full Text] [Related]
20. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]